Your browser doesn't support javascript.
SARS CoV-2 Antibody Persistence During Induction Chemotherapy for Pediatric T-Cell Acute Lymphoblastic Leukemia.
Pearce, Janice; Friar, Simon; Jigoulina, Galina; Bate, Jessica.
  • Pearce J; Department of Paediatric Oncology Southampton Children's Hospital.
  • Friar S; Southampton Specialist Virology Centre University Hospital Southampton NHS Foundation Trust, Southampton, England.
  • Jigoulina G; Department of Paediatric Oncology Southampton Children's Hospital.
  • Bate J; Department of Paediatric Oncology Southampton Children's Hospital.
J Pediatr Hematol Oncol ; 43(8): e1258-e1259, 2021 11 01.
Article in English | MEDLINE | ID: covidwho-1202171

Full text: Available Collection: International databases Database: MEDLINE Main subject: Antineoplastic Combined Chemotherapy Protocols / Precursor T-Cell Lymphoblastic Leukemia-Lymphoma / Induction Chemotherapy / SARS-CoV-2 / COVID-19 / Antibodies, Viral Type of study: Case report / Prognostic study Limits: Child / Humans / Male Language: English Journal: J Pediatr Hematol Oncol Journal subject: Hematology / Neoplasms / Pediatrics Year: 2021 Document Type: Article

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: International databases Database: MEDLINE Main subject: Antineoplastic Combined Chemotherapy Protocols / Precursor T-Cell Lymphoblastic Leukemia-Lymphoma / Induction Chemotherapy / SARS-CoV-2 / COVID-19 / Antibodies, Viral Type of study: Case report / Prognostic study Limits: Child / Humans / Male Language: English Journal: J Pediatr Hematol Oncol Journal subject: Hematology / Neoplasms / Pediatrics Year: 2021 Document Type: Article